Lumen Bioscience awarded $16.2 million to advance C. difficile treatment
Lumen Bioscience has been granted $16.2 million by the U.S. Department of Defense to advance its C. difficile infection (CDI) treatment.
Source: biopharma-reporter.com
Stay updated with breaking news from Lumen Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lumen Bioscience has been granted $16.2 million by the U.S. Department of Defense to advance its C. difficile infection (CDI) treatment.